These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28300289)

  • 1. Dehydrocostus Lactone Suppresses Proliferation of Human Chronic Myeloid Leukemia Cells Through Bcr/Abl-JAK/STAT Signaling Pathways.
    Cai H; Qin X; Yang C
    J Cell Biochem; 2017 Oct; 118(10):3381-3390. PubMed ID: 28300289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Dehydrocostus Lactone on Proliferation of K562 Cells and Its Mechanism].
    Cai H; Yang CH; He XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1436-1439. PubMed ID: 31607295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
    Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costunolide promotes imatinib-induced apoptosis in chronic myeloid leukemia cells via the Bcr/Abl-Stat5 pathway.
    Cai H; He X; Yang C
    Phytother Res; 2018 Sep; 32(9):1764-1769. PubMed ID: 29701267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation.
    Dong B; Liang Z; Chen Z; Li B; Zheng L; Yang J; Zhou H; Qu L
    Sci China Life Sci; 2018 Sep; 61(9):999-1009. PubMed ID: 30054832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphenol tri-vanillic ester 13c inhibits P-JAK2V617F and Bcr-Abl oncokinase expression in correlation with STAT3/STAT5 inactivation and apoptosis induction in human leukemia cells.
    Trécul A; Morceau F; Gaigneaux A; Orsini M; Chateauvieux S; Grandjenette C; Dicato M; Diederich M
    Cancer Lett; 2013 Oct; 340(1):30-42. PubMed ID: 23811288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells.
    Al-Rawashde FA; Wan Taib WR; Ismail I; Johan MF; Al-Wajeeh AS; Al-Jamal HAN
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3959-3965. PubMed ID: 34967577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells.
    Yang SH; Chien CM; Su JC; Chen YL; Chang LS; Lin SR
    J Biochem Mol Toxicol; 2008; 22(6):396-404. PubMed ID: 19111001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin-3-gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr/Abl-mediated p38-MAPK/JNK and JAK2/STAT3/AKT signalling pathways.
    Xiao X; Jiang K; Xu Y; Peng H; Wang Z; Liu S; Zhang G
    Clin Exp Pharmacol Physiol; 2019 Feb; 46(2):126-136. PubMed ID: 30251267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5.
    Chen Y; Zhou Q; Zhang L; Zhong Y; Fan G; Zhang Z; Wang R; Jin M; Qiu Y; Kong D
    Oncotarget; 2017 Apr; 8(17):28906-28921. PubMed ID: 28423649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression.
    Yang C; Yang J; Sun M; Yan J; Meng X; Ma T
    IUBMB Life; 2013 May; 65(5):435-44. PubMed ID: 23441067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
    Zhang JH; He YL; Zhu R; Du W; Xiao JH
    Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-carbinol induces apoptosis of chronic myelogenous leukemia cells through suppression of STAT5 and Akt signaling pathways.
    Safa M; Jafari L; Alikarami F; Manafi Shabestari R; Kazemi A
    Tumour Biol; 2017 Jun; 39(6):1010428317705768. PubMed ID: 28631564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells.
    Grimaudo S; Meli M; Di Cristina A; Ferro A; Pipitone MR; Romagnoli R; Simoni D; Dieli F; Tolomeo M
    Anticancer Drugs; 2013 Apr; 24(4):384-93. PubMed ID: 23370613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.
    Coppo P; Flamant S; De Mas V; Jarrier P; Guillier M; Bonnet ML; Lacout C; Guilhot F; Vainchenker W; Turhan AG
    Br J Haematol; 2006 Jul; 134(2):171-9. PubMed ID: 16846476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL but not JAK2 V617F inhibits erythropoiesis through the Ras signal by inducing p21CIP1/WAF1.
    Tokunaga M; Ezoe S; Tanaka H; Satoh Y; Fukushima K; Matsui K; Shibata M; Tanimura A; Oritani K; Matsumura I; Kanakura Y
    J Biol Chem; 2010 Oct; 285(41):31774-82. PubMed ID: 20663870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydrocostus lactone suppresses cell growth and induces apoptosis in recombinant human papilloma virus‑18 HaCaT cells via the PI3K/Akt signaling pathway.
    Li W; Ma YB; Mao YQ; Lin T
    Mol Med Rep; 2018 Jun; 17(6):7925-7930. PubMed ID: 29620208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect on bcr-abl signaling pathway and the mechanisms of apoptosis induction by meisoindigo in K562 cells].
    Liu BC; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):815-8. PubMed ID: 19176035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
    Brown S; Hutchinson CV; Aspinall-O'Dea M; Whetton AD; Johnson SM; Rees-Unwin K; Burthem J
    Eur J Haematol; 2014 Aug; 93(2):96-102. PubMed ID: 24617663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells.
    Kuo PL; Ni WC; Tsai EM; Hsu YL
    Mol Cancer Ther; 2009 May; 8(5):1328-39. PubMed ID: 19383849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.